Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CLOMIPRAMINE 75 MG CAPSULE

Clomipramine hydrochloride
$0.3645per EA
High Outlier

Strength

75 mg/1

Manufacturer

Ajanta Pharma USA Inc.

NDC

27241021201

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

9/17/2025

Active Ingredients

CLOMIPRAMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213897

On Market Since

12/23/2020

Pharmacological Classes

Tricyclic Antidepressant

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-10.9%

3Y

-24.4%

5Y

-59.8%

All

-82.4%

Generic Alternatives

1 alternative • Same active ingredient

CLOMIPRAMINE 75 MG CAPSULE
Generic
27241021230•Ajanta Pharma USA Inc.
$0.4093
+12% more

Related Drugs

Same classification

AMITRIPTYLINE HCL 10 MG TAB
Generic
00781148601•Sandoz Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
00781148610•Sandoz Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
16571010501•Rising Pharma Holdings Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
16571010510•Rising Pharma Holdings Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
16714025701•NorthStar Rx LLC
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
16714025702•NorthStar Rx LLC
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
16729017101•Accord Healthcare Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
29300041901•Unichem Pharmaceuticals (USA) Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
29300041910•Unichem Pharmaceuticals (USA) Inc.
$0.0342
per EA
AMITRIPTYLINE HCL 10 MG TAB
Generic
50268003715•AvPAK
$0.0342
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy